The importance of 5-hydroxytryptamine receptors in the gut
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 62 (1-2), 159-173
- https://doi.org/10.1016/0163-7258(94)90009-4
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Review article: promotility drugs in the treatment of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1993
- Treatment of Postoperative Nausea and Vomiting With OndansetronAnesthesia & Analgesia, 1991
- Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyThe Lancet, 1991
- Long-term efficacy of oral cisapride in symptomatic upper gut dysmotilityDigestive Diseases and Sciences, 1991
- A739 ONDANSETRON, A SELECTIVE SEROTONIN TYPE 3 (5-HT3) ANTAGONIST, REDUCES NAUSEA AND VOMITING IN FEMALES FOLLOWING MAJOR GYNECOLOGIC SURGERYAnesthesiology, 1990
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- A double‐blind placebo‐controlled trial of BRL 24924 on lower oesophageal sphincter pressure and gastro‐oesophageal reflux in healthy volunteersAlimentary Pharmacology & Therapeutics, 1988
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- 5-Hydroxytryptamine and Cholera SecretionScandinavian Journal of Gastroenterology, 1982